Virus infections often predispose to bacterial disease in the lung. In combination these agents will increase host symptoms and mortality compared with those found when either agent alone is acting on the host (29) . Previous experimental studies on viral-bacterial interactions in the respiratory tract have focused primarily on infection with viruses and bacteria of human origin (6, 8, 9, 13, 23, 27, 36) ; little attention has been given to combined experimental infection of animals with their natural pathogens.
Sendai virus and Pasteurella pneumotropica are natural infectious agents of mice (7, 20, 24, 31, 32) . Both agents are frequently found in mouse colonies, but there is no reported clinical disease in naturally infected mice (11, 25, 31) . Under experimental conditions, Sendai virusinfected mice develop pathologic pulmonary changes of bronchial epithelial cell desquamation, interstitial pneumonitis, and consolidation (1, 22, 34) similar to those caused by influenza virus infection in mice (18, 30, 37) . Because the I Present address: Pulmonary unit, University of Vermont College of Medicine, Department of Medicine, Burlington, Vermont 05401. Reprint requests to Dr. Jakab. pathologic changes in the lungs of mice closely resemble the lesions in influenza virus, its natural affinity for mice, and its apparent lack of pathogenicity for man, Seadai virus infection of mice makes an ideal model for the study of acute respiratory virus infections (38) .
P. pneumotropica is a potential pulmonary pathogen in mice frequently associated with outbreaks of pneumonia in mouse colonies (3, 4, 19, 24, 25) . Experimental studies have demonstrated that the pathogenicity of the Pasteurella organism is governed by the functional state of the pulmonary antibacterial defenses (10) .
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Histology. Pulmonary histologic studies on test animals were not possible, the entire lung being used for the quantitative cultures, but the extent of grossly visible consolidation of each lung was estimated and recorded. Separate groups of mice infected concurrently were used for study of pulmonary histology. The lungs of these mice were fixed in 10% formalin, sectioned at 5 um, and stained with hematoxylin and eosin (H and E).
RESULTS
Preliminary experiments had demonstrated that normal mice aerosol challenged with P. pneumotropica eliminated over 99% of the viable organisms from the lung parenchyma within 24 h. Intrapulmonary killing continued until, 72 h later, all the lungs were consistently bacteriologically sterile. Using these data, synergism, in future combined infection experiments, was defined as failure to eliminate viable P. pneumotropica from the lungs within 72 h.
Intrapulmonary killing of P. pneumotropica 6 days after Sendai virus infection. Experiments by others have demonstrated that failure of virus-infected lungs to eliminate viable bacteria is associated in time with maximum pathologic changes (9, 16, 17, 36) which, in the case of Sendai virus, developed approximately 6 days after infection. Accordingly, in two separate experiments, mice were aerosol challenged with P. pneumotropica 6 days after infection with Sendai virus (Fig. 1) . Marked synergism was observed in virus-infected mice as indicated by the stasis of the bacterial population at zero time levels for 3 days after bacterial challenge and by greatly delayed elimination of viable bacteria as compared with bacterial elimination from the lungs of nonvirus-infected mice.
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Synergism was observed in all groups as none of the mice tested eliminated the viable bacteria from their lungs within 72 h in contrast to those that were administered P. pneumotropica alone (Fig. 2) . Optimal synergism was observed when the infectious agents were given at a 6-day interval. Two days after the 6-day group was challenged with P. pneumotropica the pulmonary bacterial content was still at inoculum levels which was 1000-fold greater than in the other groups. Maximal deaths also occurred in the 6-day group (Table 3) .
Effect of viral "immunization" on synergism. To determine the effect of previous viral infection on subsequent viral bacterial interactions in the lung, mice were initially 6 U Serum hemagglutination inhibition antibody levels against Sendai virus 13 days after infection ranged from 1: 8 to 1: 128 with the geometric mean titer for the group being 1:32. On day 14 the previously infected mice were reinfected with 104 TCID,O of virus followed 6 days later by aerosol challenge with P. pneumotropica. Previous infection with Sendai virus afforded complete protection against subsequent combined challenge as the virus-immunized animals eliminated P. pneumotropica just as rapidly as the control group receiving the bacterium alone (Fig. 3) .
Effect of P. pneumotropica infection on pulmonary titers of Sendai virus. Having established that Sendai virus infection delays the subsequent elimination of the superinfecting P. pneumotropica, an experiment was performed to determine the effect of concurrent P. pneumotropica infection on Sendai virus elimination. Mice were initially infected with 104 TCID50 of Sendai virus and divided into two groups. Animals from one group received no further treatment and were sacrificed daily for 14 days to obtain pulmonary virus titers. The other group of mice were challenged with P. pneumotropica 6 days after virus infection. Immediately after bacterial infection and at daily intervals thereafter both pulmonary virus titers and P. pneumotropica counts were determined on the sacrificed mice.
Maximal virus titers of 107 TCID5O per lung, recovered from day 3 through day 5 after Sendai virus infection, and were rapidly diminished by day 9, after which no infectious virus could be recovered. Superinfection with P. pneumotropica had no effect on viral elimination (Fig.  4) .
Emergence of an endogenous Pasteurella sp. in the lungs of Sendai virus-infected animals. To detect possible bacterial contamination, lung homogenates of Sendai virusinfected animals were also plated on BHI sheep blood agar. Through day 5, lungs of virusinfected animals remained bacteriologically sterile. By day 6, however, the lungs of one of the three sacrificed mice contained alpha hemolytic streptococci, diptheroids, and the Pasteurella sp. indigenous to this particular mouse colony. On day 7 a greater number of these organisms were recovered from two of the three sacrificed mice and by day 8 pure cultures of the Pasteurella sp. were found in two mice, whereas the third contained the above assortment. After day 8 these endogenous organisms declined until by day 11 the lungs were again bacteriologically sterile (Fig. 4) . Pulmonary changes. P. pneumotropica infection alone produced no overt histopathology. In contrast, Sendai virus infection at 6 days was marked by increasing bronchial epithelial cell desquamation, interstitial pneumonitis, atelectasis, and scattered areas of consolidation. Sendai-immunized mice, subsequently reinfected with Sendai virus, showed no gross lung pathology.
Twenty-four hours after superimposing P. pneumotropica on the 6-day-old Sendai virus infection, peribronchial regions were observed to be intensely infiltrated by polymorphonuclear cells. Within 48 h some of the bronchi were completely occluded with a purulent exudate and the peribronchial inflammatory infiltrate was spreading to adjacent alveoli. Areas of consolidation in the lung parenchyma were also enlarging. By day 3 the congestion was still spreading. The histologic picture in lungs of mice succumbing to the infection at this time was that of confluent consolidation accompanied by severe hemorrhage in over 50% of the lung. (29) . In this study we Virus infection impairs the elimination of viable bacteria, whereas concurrent bacterial infection has no effect on elimination of infectious virus from the lungs. These results indicate that concomitant bacterial infection does not enhance the pathogenicity of the viral process. On the other hand, the viral process may enhance the bacterial infection by selecting pathogenic forms of the organism (5). However, this appears unlikely since impairment of pulmonary bactericidal activity by noninfectious methods, such as nephrectomy, also allows the immediate proliferation of P. pneumotropica after aerosol challenge (10) .
A positive correlation was established between gross and microscopic pathologic changes and an optimal synergistic effect. Previous immunization with Sendai virus prevented the induction of these gross pathologic changes upon subsequent infection with the virus and resulted in a failure to reproduce the synergistic effect during a subsequent dual infection. These data indicate that an active pulmonary infection with the virus is necessary for the observed synergism.
Because of the correlation between maximal viral-induced pathologic changes and optimal suppression of pulmonary bactericidal activity, it has been commonly held that failure of viral-infected lungs to clear inactivated bacteria was due to either impaired physical transport caused by bronchial epithelial desquamation, a decreased antibacterial response from the host, or an environment which was more favorable for bacterial multiplication, or both.
The findings of Green and Kass (14) concerning the disproportionate decrease in radiotracer and viable staphylococci from the lungs of mice exposed to 32P-labeled Staphylococcus aureus focused on the importance of intrapulmonary bactericidal mechanisms in contrast to transport as the main defense mechanisms in the lungs against bacterial infections. Virus infection does not impair the transport of radiolabeled bacteria from virus-infected lungs despite histologic evidence of extensive destruction of bronchial-ciliated epithelium, indicating that bacterial multiplication associated with virus infection of lungs is related to defects in pulmonary bactericidal mechanisms (22) . In situ bactericidal mechanisms of the lung have been attributed to the pulmonary macrophage (14) which kills, inactivates, or limits the growth of infectious organisms (12) . In vitro studies suggest that virus infections suppress the bactericidal functions of the phagocytes (35) , whereas in vivo studies also suggest a direct antiphagocytic action of virus on the alveolar phagocyte (G. J. Jakab and G. M. Green, 1973 , submitted for publication).
The spontaneous appearance and multiplication of endogenous Pasteurella in the pulmonary tissue of mice previously infected with Sendai virus verifies the synergism in viral-bacterial interactions seen with exogenously imposed P. pneumotropica. Similar results have been reported in the past when host resistance mechanisms were lowered by previous virus infection (27, 33, 36) or by placing mice in "cold wel air" (26) . Although in most instances the gram-negative organism recovered from the lungs of mice remained unidentified, descriptions such as "gram-negative coccobacilli" resembling Haemophilis influenzae but growing readily on plain agar (21) suggests that the organism may have been of the genus Pasteurellae. In those studies where endogenous bacteria multiplying in murine lungs after virus infection were identified, the organisms reported were Pasteurella pseudotuberculosis (36) , Haemophilus influenzae-murium (36) , and Pasteurella pneumotropica (33) .
The data presented in this investigation have a clear clinical significance. The occurrence of a synergistic effect between these two natural infectious agents in the mouse may well reflect the human condition where secondary bacterial complications with pathogens such as S. aureus, Diplococcus pneumoniae, H. influenzae, and other gram-negative organisms are frequently seen subsequent to primary viral infections. Furthermore, the appearance and proliferation of an endogenous Pasteurella in the lung parenchyma of Sendai virus-infected mice indicates that organisms which are part of the upper respiratory tract flora can be aspirated to and multiply in the lower respiratory tract during concomitant virus infection.
It is interesting to speculate that if such a synergistic effect is operative in human infection, the development of attenuated viral vaccines, administered by aerosol, might also provide an additional benefit by decreasing the incidence of secondary bacterial infections.
